We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
11 hedge funds and large institutions have $2.48M invested in Plus Therapeutics in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
21% less funds holding
Funds holding: 14 → 11 (-3)
40% less capital invested
Capital invested by funds: $4.11M → $2.48M (-$1.64M)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Holders
11
Holders Change
-3
Holders Change %
-21.43%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$259K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$4.58K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$2.29K |
| 4 |
State Street
Boston,
Massachusetts
|
+$763 |
Top Sellers
| 1 |
Two Sigma Advisers
New York
|
-$232K |
| 2 |
VF
Virtu Financial
New York
|
-$195K |
| 3 |
Two Sigma Investments
New York
|
-$187K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$111K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$86.9K |